SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cytokinetics, Incorporated ( CYTK)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
405 30 0 CYTK
Emcee:  mopgcw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
255CS: Cytokinetics Inc. (CYTK) Outperform [V] M. Aberman CP: US$ 1.77 TP: US$ 8 CAmopgcw-3/31/2009
254Inhaled....... pulmonary arterial hypertension, asthma, chronic obstructive pulscaram(o)uche-3/12/2009
253Amgen or small investor, interests overlap...... CHF <i>and/or</i>scaram(o)uche-3/12/2009
252Seems like CYTK is desperately trying to get another ball juggled up before 452 ejgopher-3/12/2009
251>> Also a smooth muscle-targeted molecule, tickler in last quarterly? <scaram(o)uche-3/12/2009
250Ah, got you. Thanks! Stock caught my eye this morning, as there was a modest bscaram(o)uche-3/11/2009
249One point to add: I was negative on the Ca2+ sensitizer as a means of treating former_pgs-3/11/2009
248The steps of force production in skeletal muscle are unique as compared to the oformer_pgs-3/11/2009
247>> As for the Ca2+ sensitizer, I do not think that is going to be a successcaram(o)uche-3/11/2009
246Item 5.02 Departure of Directors or Principal Officers; Election of Directors;scaram(o)uche-3/2/2009
245i think it was some 90 day ticker that started from delivery or start of the p2bmopgcw-2/27/2009
244>>Cytokinetics Delivers Clinical Trials Data to Inform Amgen's Option tuck-2/27/2009
243CS: Cytokinetics Inc. (CYTK) Outperform [V] M. Aberman CP: US$ 2.01 TP: US$ 8 CAmopgcw-2/11/2009
242Seekingalpha:(CYTK)Q4 2008 Earnings Call Transcript February 10, 2009 4:30 pm ETmopgcw-2/11/2009
241>>Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2008 Finatuck-2/10/2009
240I've been adding, too. Cheers, Tucktuck-2/5/2009
239fwiw, i bought another decent chunk here @ $1.95...mopgcw-2/5/2009
238CYTK makes a favorable deal with UBS related to ARS. Small potatoes, but every tuck-1/7/2009
237>>Cytokinetics Retains Development and Commercialization Rights to Ispinestuck-12/23/2008
236I agree, and still holding. Stock should get back into $6-10 range on AMGN newsmopgcw-12/19/2008
235>>Cytokinetics Announces Phase IIa Clinical Trial Results Relating to CK-1tuck-12/18/2008
234CS: Cytokinetics Inc. (CYTK) Outperform [V] M. Aberman CP: US$ 2.85 TP: US$ 11 Cmopgcw-10/31/2008
233CS: Cytokinetics Inc. (CYTK) Outperform [V] M. Aberman CP: US$ 4.89 TP: US$ 11 Cmopgcw-9/24/2008
232<reply> CYTK is a one product company. Safety will take a long time to dikenhott-9/24/2008
231Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at kenhott-9/24/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News